alexa Human Mesenchymal Stem Cell Transfusion for End Stage L

Journal of Immunooncology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Human Mesenchymal Stem Cell Transfusion for End Stage Liver Disease: A Case Series and Literature Review

Wen-Bo Meng1,2,3,4, Bing Bai1,2,3,4, Ying Li2,3,4, Jian-jun Zhang2,3,4, Yong-long Guo2,3,4, Wen-Ce Zhou2,3,4, Yan Li5* and Xun Li2,3,4*

1Special Minimally Invasive Surgery, 1st hospital of Lanzhou university, Lanzhou, China

2The Second General Surgery Department, 1st hospital of Lanzhou University, Lanzhou, China

3Hepatopancreatobiliary Surgery Institute of Gansu Province, Clinical Medical College Cancer Center of Lanzhou University, Lanzhou, China

4Key Laboratory of Biological Therapy and Regenerative Medicine Transformation, Gansu, China

5Department of Immunology, Cleveland Clinic, Cleveland, OH, USA

Corresponding Authors :
Yan Li
Department of Immunology
Cleveland Clinic, Cleveland, OH, USA
Tel: 001216-444-2200
E-mail: [email protected]
Xun Li
The Second General Surgery Department
1st Hospital of Lanzhou University, Lanzhou, China
Tel: 0931-8625200
E-mail: [email protected]

Received: October 30, 2015; Accepted: December 16, 2015; Published: December 24, 2015

Citation: Meng WB, Bai B, Li Y, Zhang JJ, Guo YL, et al. (2015) Human Mesenchymal Stem Cell Transfusion for End Stage Liver Disease: A Case Series and Literature Review. J Immunooncol 1:101. doi:10.4172/joi.1000101

Copyright: © 2015 Meng W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Decompensated liver cirrhosis is a severe, life-threatening situation in end-stage liver disease. Liver transplantation is the only effective therapy regarding on this. Unfortunately the shortage of liver donors, vast of patients died during enrolled in the waiting list. There are increasing reports of using stem cell to treat advanced liver disease nowadays worldwide, and if it could be alternative therapy in persons with end-stage liver disease is not so clear. Herein we describe a case series outcome of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) transfusions for decompensated liver cirrhosis and also reviewed the literature on stem cell therapy.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords